1.	A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: APC-10U1101, NCT01283906
2.	Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: Any Age Sponsor: Pharmaceutical / Industry Protocol IDs: CDX-353-002, NCT01660633
3.	Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675520, NCCTG-N09C6, N09C6, NCT01156142
4.	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Phase: Phase III Type: Supportive care Status: Active Age: 4 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000695718, COG-ACCL1031, ACCL1031, NCT01305200
5.	Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 603EUSA03, NCT00901732
6.	Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 6 months to 20 years Sponsor: Pharmaceutical / Industry Protocol IDs: TXA127-2010-002, NCT01554254
7.	Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WVU041011, NCT01566448
8.	Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OSU-11055, NCI-2012-00459, NCT01653106
9.	Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: D1022, NCT01653327
10.	TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation Phase: Phase I Type: Supportive care Status: Active Age: 18 to 60 Sponsor: Pharmaceutical / Industry Protocol IDs: TXA127-2010-001, NCT01300611
11.	Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 20 to 85 Sponsor: Other Protocol IDs: 12.0220, NCT01668849
12.	Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 186-03, ETH136-03D, NCT00206752
13.	TRIAD Burden of Illness Mucositis Study Phase: No phase specified Type: Natural history/Epidemiology, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: No. 200509024, NCT00336609
14.	Incidence and Factors Associated With the Development and Severity of Oral Mucositis Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HSC20050218H, NCT00575809
15.	Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HSC20090454H, NCT01066624
16.	Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC) Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: University of Iowa 2031062, NCT01194466
17.	Evaluation of the Role of Prostaglandins in Radiation-induced Mucositis Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VCC1005, NCT01252498
18.	Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ENT0032, SU-08102011-8266, 21777, NCT01576939